Click image to view full size image
We manufacture and supply Linagliptin as API (Active Pharmaceutical Ingredient). It is orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
ISO9001, GMP and FDA are available for your audits.
Product Attributes
Formal Name: 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
Synonyms: BI1356, Tradjenta, Trajenta
Molecular Formula: C25H28N8O2
Formula Weight: 472.5
Assay: 98.0% ~102.0%
Appearance: Off- white Crystalline Powder
Our Productions of Linagliptin API and Intermediates
|
Product Name |
CAS No. |
|
Linagliptin API |
668270-12-0 |
|
Quinazoline, 2-(chloromethyl)-4-methyl- |
109113-72-6 |
|
8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione |
666816-98-4 |
|
(R)-3-(Boc-Amino)Piperidine |
309956-78-3 |
|
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine |
853029-57-9 |
|
3-Methyl-xanthine |
1076-22-8 |
Package
Shipping
You can choose your own freight forwarder or we can send through TNT, DHL and other channels according to your needs.
http://www.sdsihuan.com/